Literature DB >> 23326250

Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012.

S Hoffjan1.   

Abstract

Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue characterized by early development of thoracic aortic aneurysms/dissections together with symptoms of the ocular and skeletal systems. While most patients/families with a classic phenotypic expression of MFS harbour mutations in the gene encoding fibrillin-1 (FBN1), genetic studies of the recent years revealed that the clinical features, as well as the mutated genes, show a high degree of overlap between MFS and other connective tissue diseases (e.g. Loeys-Dietz syndrome, Ehlers-Danlos syndrome, familial thoracic aneurysms and dissections and others). We summarize herein the current knowledge about the wide spectrum of differential diagnoses and their genetic background as well as novel therapeutic approaches in order to provide appropriate counselling and clinical follow-up for the patients.

Entities:  

Keywords:  Connective tissue disorders; Ehlers-Danlos syndrome; Loeys-Dietz syndrome; Marfan syndrome

Year:  2012        PMID: 23326250      PMCID: PMC3542934          DOI: 10.1159/000339441

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  75 in total

Review 1.  Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction.

Authors:  Dianna M Milewicz; Dong-Chuan Guo; Van Tran-Fadulu; Andrea L Lafont; Christina L Papke; Sakiko Inamoto; Carrie S Kwartler; Hariyadarshi Pannu
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

Review 2.  Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome.

Authors:  Alexander W Hartog; Romy Franken; Aeilko H Zwinderman; Maarten Groenink; Barbara J M Mulder
Journal:  Expert Opin Pharmacother       Date:  2012-03-07       Impact factor: 3.889

Review 3.  TGF-β signaling in aortic aneurysm: another round of controversy.

Authors:  Fuyu Lin; Xiao Yang
Journal:  J Genet Genomics       Date:  2010-09       Impact factor: 4.275

4.  Vascular Ehlers-Danlos syndrome: a case with fatal outcome.

Authors:  Paulo Morais; Alberto Mota; Catarina Eloy; José Manuel Lopes; Fátima Torres; Aida Palmeiro; Purificação Tavares; Filomena Azevedo
Journal:  Dermatol Online J       Date:  2011-04-15

5.  Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome.

Authors:  T Radonic; P de Witte; M Groenink; R A C M de Bruin-Bon; J Timmermans; A J H Scholte; M P van den Berg; M J H Baars; J P van Tintelen; M Kempers; A H Zwinderman; B J M Mulder
Journal:  Clin Genet       Date:  2011-03-31       Impact factor: 4.438

6.  The clinical spectrum of complete FBN1 allele deletions.

Authors:  Yvonne Hilhorst-Hofstee; Ben C J Hamel; Joke B G M Verheij; Marry E B Rijlaarsdam; Grazia M S Mancini; Jan M Cobben; Cindy Giroth; Claudia A L Ruivenkamp; Kerstin B M Hansson; Janneke Timmermans; Henriette A Moll; Martijn H Breuning; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2010-11-10       Impact factor: 4.246

7.  Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.

Authors:  Fabiana I Gambarin; Valentina Favalli; Alessandra Serio; Mario Regazzi; Michele Pasotti; Catherine Klersy; Roberto Dore; Savina Mannarino; Mario Viganò; Attilio Odero; Simona Amato; Luigi Tavazzi; Eloisa Arbustini
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-04       Impact factor: 2.160

8.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.

Authors:  Paul J Coucke; Andy Willaert; Marja W Wessels; Bert Callewaert; Nicoletta Zoppi; Julie De Backer; Joyce E Fox; Grazia M S Mancini; Marios Kambouris; Rita Gardella; Fabio Facchetti; Patrick J Willems; Ramses Forsyth; Harry C Dietz; Sergio Barlati; Marina Colombi; Bart Loeys; Anne De Paepe
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

9.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD.

Authors:  Marjolijn Renard; Bert Callewaert; Machteld Baetens; Laurence Campens; Kay MacDermot; Jean-Pierre Fryns; Maryse Bonduelle; Harry C Dietz; Isabel Mendes Gaspar; Diogo Cavaco; Eva-Lena Stattin; Constance Schrander-Stumpel; Paul Coucke; Bart Loeys; Anne De Paepe; Julie De Backer
Journal:  Int J Cardiol       Date:  2011-09-19       Impact factor: 4.164

Review 10.  Congenital contractural arachnodactyly (Beals syndrome).

Authors:  Ergül Tunçbilek; Yasemin Alanay
Journal:  Orphanet J Rare Dis       Date:  2006-06-01       Impact factor: 4.123

View more
  12 in total

1.  A novel fibrillin 1 gene mutation leading to marfan syndrome with minimal cardiac features.

Authors:  E Martínez-Quintana; F Rodríguez-González; P Garay-Sánchez; A Tugores
Journal:  Mol Syndromol       Date:  2014-02-27

2.  A novel mutation in fibrillin-1 gene identified in a Chinese family with marfan syndrome.

Authors:  Dan-Li Liu; Juan-Hui Cao; Jie Yang; Fen He; Yun Wang; Ning Fan; Xu-Yang Liu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Marfan syndrome: current perspectives.

Authors:  Guglielmina Pepe; Betti Giusti; Elena Sticchi; Rosanna Abbate; Gian Franco Gensini; Stefano Nistri
Journal:  Appl Clin Genet       Date:  2016-05-09

Review 4.  Shprintzen-Goldberg syndrome: a rare disorder.

Authors:  Sankalp Yadav; Gautam Rawal
Journal:  Pan Afr Med J       Date:  2016-04-25

Review 5.  Genetic Evaluation, Familial Screening and Exercise.

Authors:  Ricardo Stein; Juan Pablo Trujillo; Anderson Donelli da Silveira; Arsonval Lamounier Júnior; Lorenzo Monserrat Iglesias
Journal:  Arq Bras Cardiol       Date:  2017-03-06       Impact factor: 2.000

6.  Open repair of an aortic aneurysm in a patient with Loeys-Dietz syndrome using Gore hybrid vascular branch grafts.

Authors:  Sabine Wipper; Nikolaos Tsilimparis; Tilo Kölbel; Günter Daum; Yskert von Kodolitsch; E Sebastian Debus
Journal:  J Vasc Surg Cases       Date:  2015-04-18

Review 7.  Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling.

Authors:  Andrea Conidi; Veronique van den Berghe; Danny Huylebroeck
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

8.  Novel mutation in FBN1 causes ectopia lentis and varicose great saphenous vein in one Chinese autosomal dominant family.

Authors:  Qing Fu; Peng Liu; Qingsheng Lu; Feng Wang; Hui Wang; Wei Shen; Fei Xu; Lin Liu; Yuri V Sergeev; Ruifang Sui
Journal:  Mol Vis       Date:  2014-06-12       Impact factor: 2.367

Review 9.  α-Smooth Muscle Actin and ACTA2 Gene Expressions in Vasculopathies.

Authors:  Shi-Min Yuan
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

Review 10.  The Pathophysiological Significance of Fibulin-3.

Authors:  Imogen Livingstone; Vladimir N Uversky; Dominic Furniss; Akira Wiberg
Journal:  Biomolecules       Date:  2020-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.